Prostate Cancer

Access to high-quality radiology services plays a critical role in the diagnosis, treatment, and research of prostate cancer. Variability in the availability of advanced imaging technologies can contribute to delays in detection and intervention, impacting clinical outcomes. Continued investment in state-of-the-art radiology infrastructure and coordinated care delivery is essential to support timely diagnosis and optimal management. Advances in prostate cancer theranostic imaging and targeted therapeutic agents have significantly expanded diagnostic precision and treatment options, enabling more personalized and effective care pathways.